Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Molecular diagnostics and predictors in thyroid cancer.

Nikiforova MN, Nikiforov YE.

Thyroid. 2009 Dec;19(12):1351-61. doi: 10.1089/thy.2009.0240. Review.

PMID:
19895341
2.

Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.

Eszlinger M, Krogdahl A, Münz S, Rehfeld C, Precht Jensen EM, Ferraz C, Bösenberg E, Drieschner N, Scholz M, Hegedüs L, Paschke R.

Thyroid. 2014 Feb;24(2):305-13. doi: 10.1089/thy.2013.0278. Epub 2013 Oct 29.

PMID:
23837487
3.

From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.

Albarel F, Conte-Devolx B, Oliver C.

Ann Endocrinol (Paris). 2012 Jun;73(3):155-64. doi: 10.1016/j.ando.2012.03.002. Epub 2012 Apr 13. Review.

PMID:
22503804
4.

Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.

Bongiovanni M, Molinari F, Eszlinger M, Paschke R, Barizzi J, Merlo E, Giovanella L, Fasolini F, Cattaneo F, Ramelli F, Mazzucchelli L, Frattini M.

Cytopathology. 2015 Oct;26(5):288-96. doi: 10.1111/cyt.12226. Epub 2014 Dec 8.

PMID:
25487739
5.

Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules.

Buryk MA, Monaco SE, Witchel SF, Mehta DK, Gurtunca N, Nikiforov YE, Simons JP.

Int J Pediatr Otorhinolaryngol. 2013 Oct;77(10):1697-700. doi: 10.1016/j.ijporl.2013.07.029. Epub 2013 Aug 9.

PMID:
23993207
6.

Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.

Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bösenberg E, Narz F, Hegedüs L, Paschke R, Eszlinger M.

Thyroid. 2012 Oct;22(10):1025-30. doi: 10.1089/thy.2011.0391.

7.

Triage of the indeterminate thyroid aspirate: What are the options for the practicing cytopathologist?

Onenerk AM, Pusztaszeri MP, Canberk S, Faquin WC.

Cancer. 2017 Jun;125(S6):477-485. doi: 10.1002/cncy.21828.

PMID:
28609009
8.

Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.

Liu S, Gao A, Zhang B, Zhang Z, Zhao Y, Chen P, Ji M, Hou P, Shi B.

Exp Mol Pathol. 2014 Oct;97(2):292-7. doi: 10.1016/j.yexmp.2014.08.005. Epub 2014 Aug 8.

PMID:
25111330
9.

Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgery.

Mehta V, Nikiforov YE, Ferris RL.

Head Neck. 2013 Oct;35(10):1499-506. doi: 10.1002/hed.23140. Epub 2012 Sep 13. Review.

PMID:
22972563
10.

Molecular diagnostics of thyroid tumors.

Nikiforov YE.

Arch Pathol Lab Med. 2011 May;135(5):569-77. doi: 10.1043/2010-0664-RAIR.1. Review.

PMID:
21526955
11.

Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.

Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.

Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302. Epub 2015 Jul 7.

PMID:
26152656
12.

Molecular analysis of thyroid tumors.

Bhaijee F, Nikiforov YE.

Endocr Pathol. 2011 Sep;22(3):126-33. doi: 10.1007/s12022-011-9170-y. Review.

PMID:
21739166
13.
14.

Molecular analysis of thyroid tumors.

Nikiforov YE.

Mod Pathol. 2011 Apr;24 Suppl 2:S34-43. doi: 10.1038/modpathol.2010.167. Review.

15.

Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis.

Filicori F, Keutgen XM, Buitrago D, AlDailami H, Crowley M, Fahey TJ 3rd, Zarnegar R.

Surgery. 2011 Dec;150(6):1085-91. doi: 10.1016/j.surg.2011.09.009.

PMID:
22136825
16.

Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.

Paskaš S, Janković J, Živaljević V, Tatić S, Božić V, Nikolić A, Radojković D, Savin S, Cvejić D.

Cancer Cytopathol. 2015 Aug;123(8):471-9. doi: 10.1002/cncy.21554. Epub 2015 Apr 27.

17.

Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas.

Proietti A, Borrelli N, Giannini R, Romani R, Di Coscio G, Quilici F, Rago T, Miccoli P, Vitti P, Basolo F.

Cancer Cytopathol. 2014 Oct;122(10):751-9. doi: 10.1002/cncy.21454. Epub 2014 Jun 9.

18.

A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.

Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G.

Thyroid. 2009 Aug;19(8):837-42. doi: 10.1089/thy.2009.0074.

PMID:
19534623
19.

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN.

J Clin Endocrinol Metab. 2009 Jun;94(6):2092-8. doi: 10.1210/jc.2009-0247. Epub 2009 Mar 24.

PMID:
19318445
20.

Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.

Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.

Cytopathology. 2014 Jun;25(3):146-54. doi: 10.1111/cyt.12125. Epub 2014 Jan 12.

PMID:
24417615

Supplemental Content

Support Center